1/18/2006

U.S. government researchers have determined people who lack the CCR5 cell surface protein, and thus are highly HIV resistant, may be more susceptible to the West Nile virus than people with the protein. The NIH researchers said the discovery identifies the first genetic risk factor for the West Nile virus and could allow physicians to make better decisions about HIV treatment with CCR5-blocking drugs.

Full Story:
HealthDay News

Related Summaries